InVita invests in Transplant Connect to expand software solutions for human biologics

Jan. 20, 2022

InVita Healthcare Technologies, a software provider for complex medical, forensic and community care environments, announced it has invested in Transplant Connect, a software provider for the donation and transplantation field.

This strategic investment will help accelerate the continued expansion of Transplant Connect’s iTransplant platform and iReferral automated donor referral technology.

The platform supports nearly 75% of all deceased organ, tissue and eye donation in the United States and is used by more than 12,500 medical professionals across more than 100 organ, tissue, eye and birth tissue organizations around the world.

InVita provides chain of custody software technologies for complex medical, forensic and community care environments. InVita’s solutions optimize supply chains, sample tracking, and visibility across blood and plasma operations, the tissue and implant lifecycle, and environments spanning DNA and forensics.  

InVita’s solutions support increased compliance and cost control, reduced risk, and improved patient and public safety outcomes.

Invita Healthcare release